Despite considerable public and media concern, little attention has been devoted to prevention or early detection of substance use during pregnancy. A limited literature suggests that this lack of attention stems from a lack of policies or procedures for systematically identifying substance-using pregnant women and substance-exposed neonates in health care institutions. Based on interviews in local hospitals, study data reveal many disincentives to detecting substance exposure. For the most part, detection policies are not being developed or implemented, although hospitals serving poor communities are more likely to have such policies. Policy implications are discussed, including the appropriateness of mandated detection policies and whether such policies should be developed at the state or federal level.
Originally published in: Journal of Drug Issues, v. 23, no. 3, Summer 1993, pp. 375-386.
This report is part of the RAND reprint series. The Reprint was a product of RAND from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.